Clik here to view.
QuiO, SHL Group partner for connected drug-delivery tech
SHL Group and the New York-based startup QuiO announced today that the two companies have inked a strategic partnership to combine SHL’s drug-delivery systems and QuiO’s ConnectedRx solution. As part...
View ArticleClik here to view.
FDA chief to big pharma: ‘End the shenanigans’
FDA commissioner Dr. Scott Gottlieb yesterday scolded pharmaceutical companies that employ tactics to stifle generic drug competition, calling on them to “end the shenanigans.” At this week’s Federal...
View ArticleClik here to view.
Aerie Pharmaceuticals misses EPS estimates by 7 cents in Q3
Shares in Aerie Pharmaceuticals (NSDQ:AERI) fell slightly today after the company missed earnings expectations on Wall Street with its third quarter results. The Irvine, Calif.-based company posted a...
View ArticleClik here to view.
OncoSec Medical names new CEO | Personnel Moves – Nov. 9, 2017
OncoSec Medical (NSDQ:ONCS) announced earlier this week that the company’s co-founder, Punit Dhillon, would step down as CEO and continue to serve as president while Daniel O’Connor takes over the...
View ArticleClik here to view.
Shares in Titan Pharmaceuticals fall after Q3 miss
Shares in Titan Pharmaceuticals (NSDQ:TTNP) fell today after the company missed expectations on Wall Street with its third quarter results. The San Francisco, Calif.-based company posted a net loss of...
View ArticleClik here to view.
Innovus inks deal to sell Acon’s glucose monitoring kit
Innovus Pharmaceuticals (OTC:INNV) announced today that it has inked an agreement with its current partner, Acon Laboratories, to sell Acon’s FDA-cleared glucose monitor, test strips and lancet device....
View ArticleClik here to view.
Q Biomed looks to dust off shelved cancer pain drug
Denis Corin has spent the last 13 years in the biopharmaceutical industry watching and learning from scientists and companies that fail. “I’ve seen so many promising and innovative young technologies...
View ArticleClik here to view.
EMD Serono wins FDA nod for redesigned pen injector
Merck KGaA‘s biopharma biz, EMD Serono, said today that it won FDA approval for a redesigned version of its Gonal-f RFF Redi-ject pen injector. The device, which was first approved in 2013, is designed...
View ArticleClik here to view.
Study: Glytec’s diabetes management tech improves care for patients leaving...
A prospective study conducted by Eastern Virginia Medical School showed that patients had no diabetes-related readmissions or ER visits within 30 days of leaving the hospital when providers used the...
View ArticleClik here to view.
India signals shift on stent pricing cap
India’s National Pharmaceutical Pricing Authority is slated to revisit its decision to impose price caps on coronary stents in February of 2018 and it is looking for input from manufacturers, the...
View ArticleClik here to view.
Urotronic launches feasibility trial of drug-coated balloon
Urotronic is launching a feasibility trial of its drug-coated balloon in men with narrowed urethras, according to StarTribune. The Plymouth, Minn.-based company’s Optilume device is inserted into a...
View ArticleClik here to view.
FDA approves first pill with sensor to track ingestion
The FDA today approved Abilify MyCite, the first drug in the U.S. to have an ingestible sensor embedded within the pill that can track if the medication was taken. The drug-device combination product...
View ArticleClik here to view.
OncoSec Medical lands $9.3m in warrant exercise deal
OncoSec Medical (NSDQ:ONCS) said yesterday that it inked a warrant exercise agreement with unnamed holders of outstanding warrants to buy up to 5.5 million shares of the company’s common stock at an...
View ArticleClik here to view.
Appeals court affirms ruling in United Therapeutics, SteadyMed patent spat
A federal appeals court has affirmed an earlier ruling by the Patient Trial and Appeal Board of the U.S. Patent and Trademark Office, invalidating 22 claims of a patent owned by United Therapeutics...
View ArticleClik here to view.
Scilex seeks EU nod for ZTlido lidocaine patch
Sorrento Therapeutics (NSDQ:SRNE) subsidiary Scilex Pharmaceuticals said today that it filed a marketing authorization application seeking approval for its ZTlido lidocaine patch. The San Diego,...
View ArticleClik here to view.
Cardinal Health to deal China biz for $1.2B
Cardinal Health (NYSE:CAH) said yesterday that it agreed to a $1.2 billion deal with Shanghai Pharmaceuticals Holding for portions of its business in China. The deal covers Dublin, Ohio-based...
View ArticleClik here to view.
Study: Head-to-head comparison of opioid use disorder therapies finds...
A study published today in The Lancet found that two different therapies used to treat opioid use disorder – an extended-release naltrexone injection and a combination of buprenorphine and naloxone –...
View ArticleClik here to view.
BioCorRx inks deal with Nat’l Institute on Drug Abuse
BioCorRx (OTC:BICX) said today that it inked a confidentiality agreement with the National Institute on Drug Abuse, which will allow the group to share information and potentially work together on...
View ArticleClik here to view.
Bigfoot Biomedical CEO hits back against CMS over data-sharing decision
Bigfoot Biomedical CEO Jeffrey Brewer has spoken out about a recent data-sharing decision made by CMS, saying that he plans to lobby Medicare to reverse its latest move. Earlier this year, CMS said it...
View ArticleClik here to view.
Pavmed shares climb after Q3 EPS beat
Shares in Pavmed Inc. (NSDQ:PAVM) rose today after the medical device maker beat expectations on Wall Street with its third quarter results. The N.Y.-based company posted a net loss of -$5.37 million,...
View Article